Study of Treatment for Opioid Dependence and Anxiety Disorders



Status:Recruiting
Conditions:Anxiety, Psychiatric, Gastrointestinal
Therapuetic Areas:Gastroenterology, Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:2/8/2019
Start Date:January 2015
End Date:March 2020
Contact:Rebecca K McHugh, PhD
Email:kmchugh@mclean.harvard.edu
Phone:6178553169

Use our guide to learn which trials are right for you!

Behavioral Treatment Development for Co-occurring Opioid Dependence and Anxiety Disorders

Anxiety is highly prevalent among individuals with opioid dependence and confers greater risk
for continued opioid use and poor treatment outcomes. However, there are currently no
efficacious treatments available for co-occurring opioid dependence and anxiety. The ultimate
aims of this trial are the development and testing of a novel integrated cognitive behavioral
treatment (I-CBT) for co-occurring opioid dependence and anxiety disorders. This clinical
trial consists of two phases: (1) open-trial pilot (2) randomized control trial. We
hypothesize that I-CBT will be a feasible and acceptable treatment that will result in
significant reductions in anxiety and opioid use.

This Stage 1 behavioral treatment development trial involves two stages: manual development
and pilot testing in an open trial, and a small randomized controlled trial. In both phases,
opioid use and anxiety symptoms will be measured as the primary clinical outcome, along with
measures of feasibility and patient satisfaction. These results will be used to further
refine the treatment manual and to evaluate whether this treatment may enhance outcomes for
adults with co-occurring opioid dependence and anxiety disorders.

Inclusion Criteria:

- age 18 or older

- meet current Diagnostic and Statistical Manual of Mental Disorders 5th edition
diagnostic criteria for opioid use disorder

- currently prescribed pharmacotherapy for opioid dependence

- have used opioids illicitly within the previous 90 days

- clinically-significant anxiety

- meet current diagnostic criteria for a Diagnostic and Statistical Manual of Mental
Disorders 5th edition anxiety disorder

- able to read and provide informed consent

- intend to remain in the geographical area for the duration of the study period

Exclusion Criteria:

- meet criteria for a current substance use or psychiatric disorder requiring a level of
care higher than outpatient

- currently receiving cognitive behavioral therapy

- recent initiation of a psychiatric medication, defined as less than 4 weeks on a
stable dose; not including PRN medications for sleep

- are receiving and taking an as-needed (PRN) prescription for benzodiazepines

- presence of a psychiatric or medical condition that would interfere with participation
or that requires additional care (e.g. psychosis, acute suicidality)

- were admitted to McLean Hospital for their current treatment episode on an involuntary
status
We found this trial at
1
site
115 Mill St
Belmont, Massachusetts 02478
(617) 855-2000
Principal Investigator: Rebecca K McHugh, PhD
McLean Hospital McLean Hospital is a comprehensive psychiatric hospital committed to providing easy access to...
?
mi
from
Belmont, MA
Click here to add this to my saved trials